LifeSci Advisors provides companies in the life sciences industry with comprehensive solutions to communications and investor outreach. LifeSci Advisors increases client visibility within the investment community and educates investors on opportunities offered by these companies. Our core capabilities include non-deal roadshow planning and execution, KOL Events/R&D Days, corporate communications, capital markets solutions, corporate governance, equity research through our affiliate LifeSci Capital (FINRA/SIPC), and public relations through our affiliate LifeSci Public Relations.
With a local presence in New York, Chicago, Boston, London, Geneva, Paris, and Tel-Aviv, LifeSci Advisors provides high quality service for clients with our intensive healthcare sector specialization. The LifeSci team has 350+ years of healthcare experience in sell-side research, institutional equity sales, capital markets/investment banking, institutional investing, VC investing and strategic IR advisory. We have long-standing relationships with key investors and senior professionals across the industry. Our combination of healthcare expertise and investment banking experience allows us to provide objective, unbiased capital markets advice for private and public biotech, specialty pharma, medical technology, diagnostics, and healthcare services companies.
The LifeSci Advisors Approach
LifeSci Advisors employs a “client as partner” approach to our company relationships. From the beginning of each client relationship, we immerse ourselves in the subject matter and work closely with the client to develop an unparalleled and thorough understanding of the value of their business, the opportunities they’re addressing and their unique value proposition. With this insight, LifeSci Advisors provides each client with thoughtful and strategic recommendations related to corporate communications, investor targeting, investor outreach and capital markets solutions. These recommendations are specifically tailored to each client’s unique needs and designed to help them achieve their investor relations goals. We strive to effectively communicate each client’s investment thesis, which builds important momentum for the company’s investment story.